NCT03847207View on ClinicalTrials.gov

A Study in Healthy Subjects to Assess the Safety, Tolerability, PK and PD of HTL0030310

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 23, 2019

Primary Completion Date

March 5, 2020

Study Completion Date

March 5, 2020

Conditions
Healthy
Interventions
DRUG

HTL0030310

Solution for Subcutaneous injection

DRUG

Pasireotide

Pasireotide 600 μg for subcutaneous injection

DRUG

Placebo

Matching placebo Solution

Trial Locations (1)

NG11 6JS

Quotient Sciences, Nottingham

All Listed Sponsors
lead

Nxera Pharma UK Limited

INDUSTRY

NCT03847207 - A Study in Healthy Subjects to Assess the Safety, Tolerability, PK and PD of HTL0030310 | Biotech Hunter | Biotech Hunter